Directed evolution of gold nanoparticle delivery to cells

scientific article

Directed evolution of gold nanoparticle delivery to cells is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1039/B920865H
P932PMC publication ID3826538
P698PubMed publication ID20066302

P50authorKonstantin SokolovQ50637499
P2093author name stringAndrew D Ellington
Na Li
Timothy Larson
Hong H Nguyen
P2860cites workPaclitaxel-Functionalized Gold NanoparticlesQ56443599
SERS opens a new way in aptasensor for protein recognition with high sensitivity and selectivityQ60147091
Gold nanoparticle-based colorimetric assay for the direct detection of cancerous cells.Q64998134
Properties of the receptor for epidermal growth factorQ70212189
Real-time vital optical imaging of precancer using anti-epidermal growth factor receptor antibodies conjugated to gold nanoparticlesQ73344148
Oligonucleotide loading determines cellular uptake of DNA-modified gold nanoparticlesQ81588343
Autocrine, paracrine and juxtacrine signaling by EGFR ligandsQ36176790
Nanoparticles for bioimaging.Q36556983
The effect of particle design on cellular internalization pathwaysQ36954579
Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidanceQ37089559
Remote optical switch for localized and selective control of gene interference.Q37419607
Therapeutic applications of DNA and RNA aptamers.Q37571996
Cell-specific internalization study of an aptamer from whole cell selectionQ38295147
Technical and biological issues relevant to cell typing with aptamersQ38356064
Polyvalent DNA nanoparticle conjugates stabilize nucleic acidsQ38357970
Gene regulation with polyvalent siRNA-nanoparticle conjugatesQ39745672
Aptamer-targeted gold nanoparticles as molecular-specific contrast agents for reflectance imagingQ39977008
In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tagsQ40031376
The biochemistry and physiology of the receptor-kinase for epidermal growth factorQ40136700
Oligonucleotide-modified gold nanoparticles for intracellular gene regulation.Q40278223
Liposome-cell interactions in vitro: effect of liposome surface charge on the binding and endocytosis of conventional and sterically stabilized liposomesQ41008898
Aptamer-functionalized gold nanoparticles as probes in a dry-reagent strip biosensor for protein analysisQ43484075
Conjugation with (111)In-DTPA-poly(ethylene glycol) improves imaging of anti-EGF receptor antibody C225.Q43755990
Chitosan reduced gold nanoparticles as novel carriers for transmucosal delivery of insulinQ43834081
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectnanoparticleQ61231
directed evolutionQ440681
P304page(s)392-394
P577publication date2009-11-24
P1433published inChemical CommunicationsQ426303
P1476titleDirected evolution of gold nanoparticle delivery to cells
P478volume46

Reverse relations

cites work (P2860)
Q34123063A general RNA motif for cellular transfection
Q28740749A neutralizing RNA aptamer against EGFR causes selective apoptotic cell death
Q42843994A simple and sensitive method for visual detection of phosgene based on the aggregation of gold nanoparticles
Q38096870Application of aptamers for targeted therapeutics
Q37771956Aptamer applications for targeted cancer therapy
Q35673895Aptamer technology for tracking cells' status & function
Q28066827Aptamer-Mediated Targeted Delivery of Therapeutics: An Update
Q36167027Aptamer-functionalized nanoparticles for medical applications: challenges and opportunities.
Q36298003Aptamer-mediated delivery of chemotherapy to pancreatic cancer cells
Q38324414Aptamer-mediated delivery of splice-switching oligonucleotides to the nuclei of cancer cells
Q39070782Aptamers as Therapeutics
Q38240594Aptamers as drug delivery vehicles.
Q51813594Aptamers as therapeutics.
Q36155891Aptamers for Targeted Drug Delivery
Q37853940Aptamers: turning the spotlight on cells
Q38227494Cancer active targeting by nanoparticles: a comprehensive review of literature.
Q34599718Cell-specific aptamer-mediated targeted drug delivery
Q38272165Cell-specific aptamers and their conjugation with nanomaterials for targeted drug delivery
Q38302347Cell-specific aptamers as emerging therapeutics
Q33834772Cell-type-specific, Aptamer-functionalized Agents for Targeted Disease Therapy
Q38976705Coupling Aptamers to Short Interfering RNAs as Therapeutics.
Q36365202Current progress of RNA aptamer-based therapeutics
Q34414326Design, synthesis, and characterization of nucleic-acid-functionalized gold surfaces for biomarker detection.
Q27013001EGF receptor-targeted nanocarriers for enhanced cancer treatment
Q42924806Facile controlled preparation of phosphonic acid-functionalized gold nanoparticles
Q33762078Fluorescence-activated cell sorting for aptamer SELEX with cell mixtures
Q34539526In vivo SELEX for Identification of Brain-penetrating Aptamers.
Q37885186Intracellular delivery of RNA-based therapeutics using aptamers
Q38104355Label-free methods of reporting biomolecular interactions by optical biosensors
Q37912756Molecular aptamers for drug delivery
Q34306130Multifunctional RNA nanoparticles
Q58704366Nucleic Acid Aptamers Targeting Epigenetic Regulators: An Innovative Therapeutic Option
Q38308357Nucleic acid aptamers in cancer research, diagnosis and therapy
Q42111511Nucleic acids in human glioma treatment: innovative approaches and recent results
Q36453487Preventing protein adsorption and macrophage uptake of gold nanoparticles via a hydrophobic shield
Q39862703RNA aptamers and their therapeutic and diagnostic applications
Q26778234Recent Developments in Active Tumor Targeted Multifunctional Nanoparticles for Combination Chemotherapy in Cancer Treatment and Imaging
Q51313422Selection and Application of Aptamers and Intramers.
Q33832781Selection of Nucleic Acid Aptamers Targeting Tumor Cell-Surface Protein Biomarkers
Q35740074Selective Targeting to Glioma with Nucleic Acid Aptamers
Q47187038Size dependent targeted delivery of gold nanoparticles modified with the IL-6R-specific aptamer AIR-3A to IL-6R-carrying cells
Q38309627Stabilized Interleukin-6 receptor binding RNA aptamers
Q33825496Synthesis of lipid-oligonucleotide conjugates for RNA interference studies.
Q37978315Targeting strategies for multifunctional nanoparticles in cancer imaging and therapy
Q92689096Tracking RNA with light: selection, structure, and design of fluorescence turn-on RNA aptamers
Q38298067Trends in aptamer selection methods and applications

Search more.